Clinical trial
PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria
NCT00295581 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00295581 |
|---|---|
| Title | PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria |
| Official title | Phase 1 Study of the Safety and Immunogenicity of PpPfs25/ISA51 and ScPvs25/ISA51: Transmission Blocking Vaccines for Plasmodium Falciparum and Plasmodium Vivax Malaria |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum, Plasmodium Vivax Malaria |
| Intervention type | Drug |
| Interventions | PpPfs25/ISA51 & ScPvs25/ISA51 |
| Enrollment | 0 |
| Start date | Mar 7, 2005 |
| Completion | Jun 17, 2008 |
| First posted | Feb 23, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: